Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers
Lars Forsberg, Jan Hillert, Jeff Rodgers(Swansea University), Melinda Magyari(University of Copenhagen), Tim Spelman(Peter Doherty Institute), Richard Nicholas(Swansea University), María Trojano(University of Bari Aldo Moro), Sandra Vukusic(Institut NeuroMyoGène), Dana Horáková(Charles University), Helmut Butzkueven(Monash Alfred Psychiatry Research centre), Thomas Hach(Novartis (Switzerland)), Pernilla Klyve(Karolinska Institutet), Carol Lines(Novartis (Switzerland)), Merja Soilu‐Hänninen(University of Turku), Anneke van der Walt(The Alfred Hospital), Alexander Stahmann(Unknown), David Ellenberger(L3S Research Center), Pietro Iaffaldano(University of Bari Aldo Moro), James Witts(Swansea University), Nicholas Adlard(Novartis (Switzerland)), Ryan Ramanujam(Karolinska Institutet), Luigi Pontieri(Rigshospitalet), Vladimir Bezlyak(Novartis (Switzerland)), Jiří Drahota(Charles University), Ali Manouchehrinia(Karolinska Institutet), Hanna Joensen(Rigshospitalet), Rod Middleton(Swansea University), Anna Glaser(Karolinska Institutet), Elena Flavia Mouresan(Karolinska Institutet)
Multiple Sclerosis Journal - Experimental Translational and Clinical
January 1, 2023
Cited by 13
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k
Multiple Sclerosis Severity Score
|Neurology|2005|957
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624